Agilent Technologies EPS - Earnings per Share 2010-2025 | A
Agilent Technologies annual and quarterly earnings per share history from 2010 to 2025. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Agilent Technologies EPS for the quarter ending January 31, 2025 was $1.11, a 5.93% decline year-over-year.
- Agilent Technologies EPS for the twelve months ending January 31, 2025 was $4.36, a 4.31% increase year-over-year.
- Agilent Technologies 2024 annual EPS was $4.43, a 5.73% increase from 2023.
- Agilent Technologies 2023 annual EPS was $4.19, a 0.24% increase from 2022.
- Agilent Technologies 2022 annual EPS was $4.18, a 6.09% increase from 2021.
| Agilent Technologies Annual EPS | |
|---|---|
| 2024 | $4.43 |
| 2023 | $4.19 |
| 2022 | $4.18 |
| 2021 | $3.94 |
| 2020 | $2.30 |
| 2019 | $3.37 |
| 2018 | $0.97 |
| 2017 | $2.10 |
| 2016 | $1.40 |
| 2015 | $1.20 |
| 2014 | $1.62 |
| 2013 | $2.13 |
| 2012 | $3.27 |
| 2011 | $2.85 |
| 2010 | $1.94 |
| 2009 | $-0.09 |
| Agilent Technologies Quarterly EPS | |
|---|---|
| 2025-01-31 | $1.11 |
| 2024-10-31 | $1.23 |
| 2024-07-31 | $0.97 |
| 2024-04-30 | $1.05 |
| 2024-01-31 | $1.18 |
| 2023-10-31 | $1.60 |
| 2023-07-31 | $0.38 |
| 2023-04-30 | $1.02 |
| 2023-01-31 | $1.19 |
| 2022-10-31 | $1.24 |
| 2022-07-31 | $1.10 |
| 2022-04-30 | $0.91 |
| 2022-01-31 | $0.93 |
| 2021-10-31 | $1.45 |
| 2021-07-31 | $0.86 |
| 2021-04-30 | $0.70 |
| 2021-01-31 | $0.93 |
| 2020-10-31 | $0.71 |
| 2020-07-31 | $0.64 |
| 2020-04-30 | $0.32 |
| 2020-01-31 | $0.63 |
| 2019-10-31 | $0.63 |
| 2019-07-31 | $0.60 |
| 2019-04-30 | $0.57 |
| 2019-01-31 | $1.57 |
| 2018-10-31 | $0.60 |
| 2018-07-31 | $0.73 |
| 2018-04-30 | $0.63 |
| 2018-01-31 | $-0.99 |
| 2017-10-31 | $0.54 |
| 2017-07-31 | $0.54 |
| 2017-04-30 | $0.50 |
| 2017-01-31 | $0.52 |
| 2016-10-31 | $0.38 |
| 2016-07-31 | $0.38 |
| 2016-04-30 | $0.28 |
| 2016-01-31 | $0.36 |
| 2015-10-31 | $0.42 |
| 2015-07-31 | $0.33 |
| 2015-04-30 | $0.26 |
| 2015-01-31 | $0.19 |
| 2014-10-31 | $0.05 |
| 2014-07-31 | $0.43 |
| 2014-04-30 | $0.41 |
| 2014-01-31 | $0.58 |
| 2013-10-31 | $0.63 |
| 2013-07-31 | $0.49 |
| 2013-04-30 | $0.48 |
| 2013-01-31 | $0.51 |
| 2012-10-31 | $1.21 |
| 2012-07-31 | $0.69 |
| 2012-04-30 | $0.72 |
| 2012-01-31 | $0.65 |
| 2011-10-31 | $0.83 |
| 2011-07-31 | $0.92 |
| 2011-04-30 | $0.56 |
| 2011-01-31 | $0.54 |
| 2010-10-31 | $0.83 |
| 2010-07-31 | $0.58 |
| 2010-04-30 | $0.31 |
| 2010-01-31 | $0.22 |
| 2009-10-31 | $0.08 |
| 2009-07-31 | $-0.06 |
| 2009-04-30 | $-0.29 |
| 2009-01-31 | $0.18 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $32.944B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.641B | 27.61 |
| Boston Scientific (BSX) | United States | $152.191B | 38.10 |
| Stryker (SYK) | United States | $148.126B | 30.97 |
| EssilorLuxottica (ESLOY) | France | $127.448B | 0.00 |
| Medtronic (MDT) | Ireland | $110.055B | 16.07 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.786B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.281B | 27.46 |
| ResMed (RMD) | United States | $36.314B | 27.27 |
| GE HealthCare Technologies (GEHC) | United States | $33.934B | 16.11 |
| Terumo (TRUMY) | Japan | $28.086B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $23.536B | 16.92 |
| Insulet (PODD) | United States | $22.286B | 87.48 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.433B | 12.48 |
| Baxter (BAX) | United States | $16.360B | 12.22 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.456B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.190B | 24.31 |
| Lantheus Holdings (LNTH) | United States | $5.502B | 13.88 |
| Prestige Consumer Healthcare (PBH) | United States | $4.350B | 19.43 |
| Perrigo (PRGO) | Ireland | $3.711B | 9.40 |
| ICU Medical (ICUI) | United States | $3.552B | 26.20 |
| Haemonetics (HAE) | United States | $3.528B | 15.37 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.144B | 26.13 |
| QuidelOrtho (QDEL) | United States | $2.531B | 17.41 |
| GN Store Nord (GNNDY) | Denmark | $2.188B | 18.12 |
| LeMaitre Vascular (LMAT) | United States | $1.863B | 41.65 |
| AtriCure (ATRC) | United States | $1.575B | 0.00 |
| Neogen (NEOG) | United States | $1.411B | 18.06 |
| AdaptHealth (AHCO) | United States | $1.229B | 12.48 |
| Kestra Medical Technologies (KMTS) | United States | $1.211B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.152B | 25.91 |
| BioLife Solutions (BLFS) | United States | $1.135B | 0.00 |
| InMode (INMD) | Israel | $1.043B | 9.55 |
| Phibro Animal Health (PAHC) | United States | $0.992B | 12.69 |
| Evolus (EOLS) | United States | $0.643B | 0.00 |
| CeriBell (CBLL) | United States | $0.620B | 0.00 |
| Owens & Minor (OMI) | United States | $0.552B | 4.58 |
| Curaleaf Holdings (CURLF) | Canada | $0.545B | 0.00 |
| Valneva SE (VALN) | France | $0.539B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.539B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.462B | 0.00 |
| Surmodics (SRDX) | United States | $0.387B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.357B | 0.00 |
| SNDL (SNDL) | Canada | $0.347B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.325B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.310B | 11.39 |
| Sanara MedTech (SMTI) | United States | $0.305B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.284B | 50.60 |
| Canopy Growth (CGC) | Canada | $0.268B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.261B | 0.00 |
| Cerus (CERS) | United States | $0.258B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.257B | 21.70 |
| ZimVie (ZIMV) | United States | $0.248B | 11.28 |
| Verano Holdings (VRNOF) | United States | $0.248B | 0.00 |
| Quanterix (QTRX) | United States | $0.222B | 0.00 |
| Omeros (OMER) | United States | $0.221B | 0.00 |
| Biote (BTMD) | United States | $0.218B | 6.14 |
| OraSure Technologies (OSUR) | United States | $0.200B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.177B | 14.29 |
| Organigram Global (OGI) | Canada | $0.171B | 0.00 |
| Brainsway (BWAY) | Israel | $0.167B | 51.94 |
| TriSalus Life Sciences (TLSI) | United States | $0.165B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.145B | 17.82 |
| Jin Medical (ZJYL) | China | $0.141B | 0.00 |
| Exagen (XGN) | United States | $0.123B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.107B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Agape ATP (ATPC) | $0.083B | 0.00 | |
| Fonar (FONR) | United States | $0.077B | 10.76 |
| Veru (VERU) | United States | $0.076B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.070B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Zynex (ZYXI) | United States | $0.065B | 0.00 |
| United Health Products (UEEC) | United States | $0.061B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.047B | 0.00 |
| Apyx Medical (APYX) | United States | $0.042B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.10 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |